Intuitive Surgical (ISRG), a prominent player in the robotic-assisted surgery market, has garnered significant attention from investors. Its impressive procedure outlook coupled with the rollout of da Vinci 5 has sparked optimistic reactions. Renowned investor
Israel Englander showcases faith in ISRG by considerably loading up on its stocks amidst speculations regarding the company potentially reaching a trillion-dollar valuation, though some sources believe PODD showcases better value and growth. There's strong confidence in ISRG's potential for a 13-15% growth in procedures by 2026, but concerns remain about if this will be sufficient to maintain its premium valuation. Investor attention towards ISRG has been increasing due to its promising advancements in improving surgical precision through
Artificial Intelligence (AI). Furthermore, ISRG recently faced a cyber breach, though spared surgical robots, stirring various reactions. Some experts continue to raise questions about its fair pricing due to its robust multi-year share price run and recent price pullback, balanced against ISRG's continued expansion, notable FDA clearances, and reaffirmed da Vinci growth guidance.
Intuitive Surgical ISRG News Analytics from Tue, 07 Oct 2025 07:00:00 GMT to Fri, 10 Apr 2026 20:43:34 GMT -
Rating 7
- Innovation 8
- Information 6
- Rumor 6
